[Prospects of use coryneformic bacteria drug to prevent and treat respiratory infections].

Abstract

This work shows the Codivac efficiency in its aerosol form to treat children sick of influenza and acute respiratory viral infections. Course of therapy with the Codivac drug leads to improve clinical picture and rapid elimination virus from human organism as compared with children undergone traditional therapy. Recovery is accompanied with improving of indices of cell immunity. The article shows the prospects of use Codivac to prevent and treat respiratory infections.

• Authors: E A Shmeleva, R V Vartanian, V A Aleshkin, Iu Aq Paramonova, i G Baturina, N A Malyshev
• Journal: Vestnik Rossiiskoi akademii meditsinskikh nauk (Vestn Ross Akad Med Nauk) Issue 3 Pg. 12-6 ( 2008) ISSN: 0869-6047 [Print] Russia (Federation)
• PMID: 18421903 (Publication Type: Clinical Trial, English Abstract, Journal Article)

Chemical References

• Anti-Bacterial Agents
• Bacterial Vaccines
• Codivac
• Diphtheria Toxoid

Topics

• Actinomycetales (physiology)
• Acute Disease
• Administration, Inhalation
• Adolescent
• Anti-Bacterial Agents (therapeutic use)
• Bacterial Infections (prevention & control)
• Bacterial Vaccines (therapeutic use)
• Child
• Child, Preschool
• Diphtheria Toxoid (pharmacology, therapeutic use)
• Drug Administration Schedule
• Forecasting
• Humans
• Infant
• Microbiology (trends)
• Respiratory Tract Infections (prevention & control)
• T-Lymphocytes (drug effects)
• Time Factors